HOME >> BIOLOGY >> NEWS
One-two punch knocks out fly genes

Just months after scientists decoded the complete sequence of the Drosophila (fruit fly) genome, a pair of biologists funded by the National Institute of General Medical Sciences have achieved another significant milestone: the ability to "knock out" fruit fly genes.

"This is something Drosophila scientists have wanted to do for 20 years," said Dr. Kent Golic of the University of Utah, who published the results in the June 16 issue of Science along with postdoctoral fellow Dr. Yikang Rong.

So-called "knock-out" technology is a powerful laboratory method used routinely by scientists working with certain other model systems, such as yeast and mice. But the technology has been sorely missed by the thousands of researchers worldwide who use fruit flies as a research tool to probe mysteries of the biology of plants and animals, including humans.

The new technique offers fly researchers the ability to tease apart the functions of the 13,601 genes in the fruit fly genome. With important genes, Nature has demonstrated an exquisite sense of economy: 177 of the 289 human genes that when "misspelled" are known to cause diseases in people have direct counterparts in the fly.

For decades, fly geneticists have cross-bred strains of flies in order to study their genes. But until now, scientists have not had a way to target a particular fly gene of interest by disabling, or "mutating" that gene.

Thanks to the new work, now these scientists do.

According to Dr. Golic, knocking out fly genes was by no means a sure bet. "It wasn't at all clear that this would work . . . we were scratching our heads about how to find the money to do these experiments," he said.

Dr. Golic's money came from a special NIGMS funding program for "high-risk, high-impact" grants, or R21's as they are called at NIGMS. R21-funded research projects involve high-risk experiments that often have little supporting data but that, if successful, wou
'"/>

Contact: Alison Davis
davisa@nigms.nih.gov
301-496-7301
NIH/National Institute of General Medical Sciences
14-Jun-2000


Page: 1 2 3 4

Related biology news :

1. New compound could give some types of cancer the one-two punch
2. Avastin-Tarceva combo provides one-two punch against lung cancer
3. Study suggests double punch could more efficiently kill viruses
4. Tomato packs more cancer-fighting punch
5. As bodies age, disease-fighting cells lose punch
6. Legumes found to contain starch carrying a fiber-like punch
7. Targeted therapy knocks out pediatric brain cancer in mice
8. Belgian researchers explore revolutionary approach to angiogenesis
9. Tracing genes, biologists show lizard migration is traced to Florida
10. Certain genes boost fish oils protection against breast cancer
11. Fossil genes reveal how life sheds form and function

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: One two punch knocks out fly genes

(Date:5/20/2013)... 2013) - A novel vaccine study from ... research that will be unveiled at the American Association ... meeting takes place Monday, May 20 - Wednesday, May ... , "The main goal of a vaccine is ... pathogen that causes the disease", explained Dr. Hemachand Tummala, ...
(Date:5/19/2013)... at the University of California, Davis have engineered a ... for light. They report their findings today at ... Microbiology. , "In this work, we used synthetic biology ... carbon dioxide and light energy for growth) cyanobacterial metabolism ... Jordan McEwen, the lead researcher on the study. ...
(Date:5/17/2013)... (May 18, 2013) The AGA Research Foundation announced ... the relationship between the gut microbiota, one of today,s ... disease. , The AGA Research Awards Panel selected ... Massachusetts General Hospital and Harvard Medical School, Boston, as ... Dr. Chan will receive $25,000 of funding, commencing in ...
Breaking Biology News(10 mins):Germ-fighting vaccine system makes great strides in delivery 2New gut microbiome research to explore red meat -- colorectal cancer pathway 2
(Date:5/21/2013)... Alpha Source, Inc., a Wisconsin-based ... exhibiting for the 13th consecutive year at the ... 2013 Conference and Expo. The conference brings together ... healthcare technologies. This year’s event will be held ... , The three-day event draws over 1,500 healthcare ...
(Date:5/21/2013)... NC (PRWEB) May 21, 2013 ... financial services company for clinical trials, announced today ... Spend Solutions, LLC. Clinverse’s ClinPay® FLS eClinical ... investigator payment process. SpendMD ™, Aggregate ... complete solution for tracking and reporting transfer of ...
(Date:5/21/2013)... As the R&D sector becomes increasingly ... industry to deliver better products, faster. Collaborations between ... often means turning big ideas into reality, within ... with Sensidose AB and Recipharm, is one example ... market sooner. The partnership resulted in the development ...
(Date:5/21/2013)... ROCKVILLE, Md. , May 21, 2013 /PRNewswire/ ... "Phase 1 study of margetuximab (MGAH22), an Fc-modified ... solid tumors expressing the HER2 oncoprotein," will be ... American Society of Clinical Oncology during the Developmental ... June 3 at 4:15 – 4:30 PM.  The ...
Breaking Biology Technology:Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3The Development of an Innovative Microtablet Dosage Form, a Success Story: Live Webinar Hosted by Xtalks 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 2MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer 3
Cached News: